On April 7, 2026 Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, reported that the Company will participate in two upcoming investor conferences.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
25th Annual Needham Virtual Healthcare Conference
Date and time: April 13, 2028; 10:15am EDT / 3:15pm BST
Presenter: Chief Executive Officer Dr. Christian Itin
A webcast of the presentation will be available on the "Events" page in the "Investor Relations & Media" section of the Company’s website at View Source A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.
Van Lanschot Kempen Life Sciences Conference
Management to host investor meetings
Date: April 16, 2026
Location: Amsterdam
(Press release, Autolus, APR 7, 2026, View Source [SID1234664227])